{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T07:40:00Z","timestamp":1793173200137,"version":"4.5.0"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1084259"],"award-info":[{"award-number":["OPP1084259"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1151372"],"award-info":[{"award-number":["OPP1151372"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011102","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["ADITEC"],"award-info":[{"award-number":["ADITEC"]}],"id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006510","name":"Duke University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006510","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.02582","type":"journal-article","created":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T11:27:17Z","timestamp":1572607637000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":52,"title":["IgA and IgG1 Specific to Vi Polysaccharide of Salmonella Typhi Correlate With Protection Status in a Typhoid Fever Controlled Human Infection Model"],"prefix":"10.3389","volume":"10","author":[{"given":"Lindsay C.","family":"Dahora","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celina","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel L.","family":"Spreng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick","family":"Feely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Mathura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly E.","family":"Seaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Munir","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Moses","family":"Dennison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Pollard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia D.","family":"Tomaras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,11,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e0005376","DOI":"10.1371\/journal.pntd.0005376","article-title":"The burden of typhoid fever in low- and middle-income countries: a meta-regression approach","volume":"11","author":"Antillon","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e570","DOI":"10.1016\/S2214-109X(14)70301-8","article-title":"Burden of typhoid fever in low-income and middle-income countries: a systematic, literature-based update with risk-factor adjustment","volume":"2","author":"Mogasale","year":"2014","journal-title":"Lancet Glob Health."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e00105","DOI":"10.1128\/mBio.00105-18","article-title":"Emergence of an extensively drug-resistant salmonella enterica serovar typhi clone harboring a promiscuous plasmid encoding resistance to fluoroquinolones and third-generation cephalosporins","volume":"9","author":"Klemm","year":"2018","journal-title":"MBio"},{"key":"B4","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/ng.3281","article-title":"Phylogeographical analysis of the dominant multidrug-resistant H58 clade of Salmonella Typhi identifies inter- and intracontinental transmission events","volume":"47","author":"Wong","year":"2015","journal-title":"Nat Genet"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1056\/NEJMp1803926","article-title":"Extensively drug-resistant typhoid - are conjugate vaccines arriving just in time?","volume":"379","author":"Andrews","year":"2018","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/0264-410X(90)90183-M","article-title":"Efficacy of one or two doses of Ty21a Salmonella typhi vaccine in enteric-coated capsules in a controlled field trial. Chilean Typhoid Committee","volume":"8","author":"Black","year":"1990","journal-title":"Vaccine."},{"key":"B7","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1136\/bmj.316.7125.110","article-title":"Typhoid fever vaccines: a meta-analysis of studies on efficacy and toxicity","volume":"316","author":"Engels","year":"1998","journal-title":"BMJ"},{"key":"B8","doi-asserted-by":"crossref","first-page":"5806","DOI":"10.1128\/IAI.67.11.5806-5810.1999","article-title":"Safety and immunogenicity of Vi conjugate vaccines for typhoid fever in adults, teenagers, and 2- to 4-year-old children in Vietnam","volume":"67","author":"Kossaczka","year":"1999","journal-title":"Infect Immun"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1016\/S0264-410X(98)00098-X","article-title":"Infant B cell responses to polysaccharide determinants","volume":"16","author":"Rijkers","year":"1998","journal-title":"Vaccine"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1016\/j.carres.2003.07.008","article-title":"Immunology of bacterial polysaccharide antigens","volume":"338","author":"Weintraub","year":"2003","journal-title":"Carbohydr Res"},{"key":"B11","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1146\/annurev-micro-091313-103739","article-title":"Salmonella enterica serovar Typhi and the pathogenesis of typhoid fever","volume":"68","author":"Dougan","year":"2014","journal-title":"Annu Rev Microbiol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1128\/IAI.00961-10","article-title":"The Vi capsular polysaccharide prevents complement receptor 3-mediated clearance of Salmonella enterica serotype Typhi","volume":"79","author":"Wilson","year":"2011","journal-title":"Infect Immun"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e1004306","DOI":"10.1371\/journal.ppat.1004306","article-title":"The Vi capsular polysaccharide enables Salmonella enterica serovar typhi to evade microbe-guided neutrophil chemotaxis","volume":"10","author":"Wangdi","year":"2014","journal-title":"PLoS Pathog"},{"key":"B14","first-page":"23","article-title":"Protein carriers for glycoconjugate vaccines: history, selection criteria, characterization and new trends","volume-title":"Molecules.","author":"Micoli","year":"2018"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1016\/S0140-6736(17)32149-9","article-title":"Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial","volume":"390","author":"Jin","year":"2017","journal-title":"Lancet"},{"key":"B16","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/0264-410X(95)00186-5","article-title":"Immunogenicity, efficacy and serological correlate of protection of Salmonella typhi Vi capsular polysaccharide vaccine three years after immunization","volume":"14","author":"Klugman","year":"1996","journal-title":"Vaccine"},{"key":"B17","doi-asserted-by":"publisher","first-page":"635","DOI":"10.3389\/fimmu.2014.00635","article-title":"Antibodies and protection against invasive salmonella disease","volume":"5","author":"MacLennan","year":"2014","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1016\/j.jaci.2009.09.046","article-title":"Structure and function of immunoglobulins","volume":"125","author":"Schroeder","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"3716","DOI":"10.1182\/blood-2008-09-179754","article-title":"Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses","volume":"113","author":"Bruhns","year":"2009","journal-title":"Blood"},{"key":"B20","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.molmed.2016.09.002","article-title":"Modulating antibody functionality in infectious disease and vaccination","volume":"22","author":"Gunn","year":"2016","journal-title":"Trends Mol Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.biologicals.2018.11.004","article-title":"Evaluation of two WHO first international standards for Vi polysaccharide from Citrobacter freundii and Salmonella enterica subspecies enterica serovar Typhi","volume":"57","author":"Gao","year":"2019","journal-title":"Biologicals"},{"key":"B22","doi-asserted-by":"publisher","first-page":"228ra239","DOI":"10.1126\/scitranslmed.3007730","article-title":"Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination","volume":"6","author":"Yates","year":"2014","journal-title":"Sci Transl Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"12449","DOI":"10.1128\/JVI.01708-08","article-title":"Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia","volume":"82","author":"Tomaras","year":"2008","journal-title":"J Virol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1128\/CDLI.10.5.744-750.2003","article-title":"Method for simultaneous measurement of antibodies to 23 pneumococcal capsular polysaccharides","volume":"10","author":"Biagini","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jim.2005.11.019","article-title":"A novel chemistry for conjugating pneumococcal polysaccharides to Luminex microspheres","volume":"309","author":"Schlottmann","year":"2006","journal-title":"J Immunol Methods"},{"key":"B26","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/mi.2012.107","article-title":"HIV-1 gp41 envelope IgA is frequently elicited after transmission but has an initial short response half-life","volume":"6","author":"Yates","year":"2013","journal-title":"Mucosal Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.4049\/jimmunol.1800323","article-title":"Qualified biolayer interferometry avidity measurements distinguish the heterogeneity of antibody interactions with plasmodium falciparum circumsporozoite protein antigens","volume":"201","author":"Dennison","year":"2018","journal-title":"J Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.4161\/hv.26109","article-title":"Protein carriers of conjugate vaccines: characteristics, development, and clinical trials","volume":"9","author":"Pichichero","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"B29","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3389\/fimmu.2014.00520","article-title":"IgG subclasses and allotypes: from structure to effector functions","volume":"5","author":"Vidarsson","year":"2014","journal-title":"Front Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e60583","DOI":"10.1371\/journal.pone.0060583","article-title":"Head-to-head comparison of humoral immune responses to Vi capsular polysaccharide and Salmonella Typhi Ty21a typhoid vaccines\u2013a randomized trial","volume":"8","author":"Kantele","year":"2013","journal-title":"PLoS ONE."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1093\/cid\/ciu078","article-title":"An outpatient, ambulant-design, controlled human infection model using escalating doses of Salmonella Typhi challenge delivered in sodium bicarbonate solution","volume":"58","author":"Waddington","year":"2014","journal-title":"Clin Infect Dis"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1093\/infdis\/jiu279","article-title":"Fold rise in antibody titers by measured by glycoprotein-based enzyme-linked immunosorbent assay is an excellent correlate of protection for a herpes zoster vaccine, demonstrated via the vaccine efficacy curve","volume":"210","author":"Gilbert","year":"2014","journal-title":"J Infect Dis"},{"key":"B33","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3389\/fimmu.2014.00243","article-title":"Epitope-specific antibody levels in tuberculosis: biomarkers of protection, disease, and response to treatment","volume":"5","author":"Bothamley","year":"2014","journal-title":"Front Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e01463","DOI":"10.1128\/mBio.01463-17","article-title":"Influenza virus hemagglutinin stalk-specific antibodies in human serum are a surrogate marker for in vivo protection in a serum transfer mouse challenge model","volume":"8","author":"Jacobsen","year":"2017","journal-title":"MBio."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.4049\/jimmunol.167.5.2861","article-title":"Human IgA activates the complement system via the mannan-binding lectin pathway","volume":"167","author":"Roos","year":"2001","journal-title":"J Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1128\/CVI.00131-10","article-title":"Correlates of protection induced by vaccination","volume":"17","author":"Plotkin","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1128\/CVI.00115-14","article-title":"Serum bactericidal assays to evaluate typhoidal and nontyphoidal Salmonella vaccines","volume":"21","author":"Boyd","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1016\/j.vaccine.2005.01.051","article-title":"Meningococcal surrogates of protection\u2013serum bactericidal antibody activity","volume":"23","author":"Borrow","year":"2005","journal-title":"Vaccine"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1016\/S0264-410X(03)00025-2","article-title":"Correlates of immunity for pneumococcal conjugate vaccines","volume":"21","author":"Lee","year":"2003","journal-title":"Vaccine"},{"key":"B40","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1086\/520200","article-title":"Reduction in functional antibody activity against Streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidity","volume":"29","author":"Romero-Steiner","year":"1999","journal-title":"Clin Infect Dis"},{"key":"B41","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1128\/CVI.00786-13","article-title":"Live oral Salmonella enterica serovar Typhi vaccines Ty21a and CVD 909 induce opsonophagocytic functional antibodies in humans that cross-react with S. Paratyphi A and S. Paratyphi B","volume":"21","author":"Wahid","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"3188","DOI":"10.1128\/IAI.05081-11","article-title":"Antibodies in action: role of human opsonins in killing Salmonella enterica serovar Typhi","volume":"79","author":"Lindow","year":"2011","journal-title":"Infect Immun."},{"key":"B43","first-page":"383","article-title":"IgA subclasses in various secretions and in serum","volume":"47","author":"Delacroix","year":"1982","journal-title":"Immunology."},{"key":"B44","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.4049\/jimmunol.140.11.3793","article-title":"Systemic immunization with pneumococcal polysaccharide vaccine induces a predominant IgA2 response of peripheral blood lymphocytes and increases of both serum and secretory anti-pneumococcal antibodies","volume":"140","author":"Lue","year":"1988","journal-title":"J Immunol"},{"key":"B45","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.4049\/jimmunol.144.10.3770","article-title":"Immunization of humans with polysaccharide vaccines induces systemic, predominantly polymeric IgA2-subclass antibody responses","volume":"144","author":"Tarkowski","year":"1990","journal-title":"J Immunol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1001\/jama.267.11.1489","article-title":"Avidity and bactericidal activity of antibody elicited by different Haemophilus influenzae type b conjugate vaccines. The Vaccine Study Group","volume":"267","author":"Schlesinger","year":"1992","journal-title":"JAMA."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1016\/S0264-410X(98)00458-7","article-title":"Differences in the avidity of antibodies evoked by four different pneumococcal conjugate vaccines in early childhood","volume":"17","author":"Anttila","year":"1999","journal-title":"Vaccine."},{"key":"B48","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1126\/science.1713710","article-title":"Recognition of a cell-surface oligosaccharide of pathogenic Salmonella by an antibody Fab fragment","volume":"253","author":"Cygler","year":"1991","journal-title":"Science."},{"key":"B49","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1128\/CVI.00290-08","article-title":"Thermodynamics and density of binding of a panel of antibodies to high-molecular-weight capsular polysaccharides","volume":"16","author":"Harris","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1093\/glycob\/cwv037","article-title":"Antibody recognition of carbohydrate epitopesdagger","volume":"25","author":"Haji-Ghassemi","year":"2015","journal-title":"Glycobiology"},{"key":"B51","doi-asserted-by":"publisher","first-page":"S59","DOI":"10.1093\/cid\/ciy1104","article-title":"A phase II, randomized, double-blind, controlled safety and immunogenicity trial of typhoid conjugate vaccine in children under 2 years of age in ouagadougou, Burkina Faso: A Methods Paper","volume":"68","author":"Laurens","year":"2019","journal-title":"Clin Infect Dis"},{"key":"B52","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S1473-3099(13)70241-X","article-title":"Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials","volume":"14","author":"Bhutta","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"B53","volume-title":"The Typhoid Vaccine Acceleration Consortium (TyVAC): Vaccine Effectiveness Study Designs: Accelerating the Introduction of Typhoid Conjugate Vaccines and Reducing The Global Burden of Enteric Fever","author":"Meiring","year":"2017"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.02582\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T07:10:46Z","timestamp":1695366646000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.02582\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,1]]},"references-count":53,"alternative-id":["10.3389\/fimmu.2019.02582"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.02582","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,1]]},"article-number":"2582"}}